LBO France, a private equity firm, led a $74m Series C funding round in Diabeloop, a diabetes company, with participation from Terumo Corporation, Innovacom, CERITD, CEMAG invest, Kreaxi, Supernova Invest, AGIR A DOM., Crédit Agricole, Odyssée Venture, Sofimac and Promontoires. “Diabeloop’s team has developed a unique data driven product that has the potential to revolutionize the daily life of millions of diabetic patients by taking away most of their daily mental burden and significantly improving the control of their disease. We are eager to join the investor base and help the company become a global leader in diabetes closed-loop software solutions,” Valery Huot, Partner, LBO France Partner and Head of Venture.